Photo: isbtweb.org
Mar 3, 2026, 14:21
Webinar on CAR-T Cells – Heterogeneity, Quality Control, and Adverse Events – ISBT
International Society of Blood Transfusion (ISBT) shared a post on LinkedIn:
“ISBT Webinar: Let’s talk CAR-T cells – heterogeneity, quality control and adverse events.
4 March 2026 | 17:00–18:00 CET
Join Oulghazi Salim for an accessible introduction to CAR-T cell therapy, covering clinical applications, cellular heterogeneity, quality control advances, and associated adverse events.
Ideal for scientists, transfusion professionals, MDs, and MSc/PhD students.
Register now and be part of the conversation”
Stay updated with Hemostasis Today.
-
Aug 15, 2026, 11:42Tasmin Hassan: Explainable AI for Anemia Severity Prediction at IEEE SPICSCON 2026
-
Aug 15, 2026, 11:36Ana Sachetto: Challenges in Extracellular Vesicle Analysis by Flow Cytometry
-
Aug 15, 2026, 11:20Saifur Rahman Chowdhury: Guidelines for Managing Critical Bleeding in ITP
-
Aug 15, 2026, 10:16Tracy Cen: Sharper Portal Venous Imaging for Precise Veterinary Diagnosis
-
Aug 15, 2026, 09:54Ryan Noik: Transforming Coagulation Care Through Precision Diagnostics
-
Aug 14, 2026, 23:18Claire Hills: New Paper on Immune Surveillance and Immune Evasion of Senescent Cells
-
Aug 14, 2026, 23:16Are We Overlooking What Matters Most to Women with Von Willebrand Disease? – RPTH Journal
-
Aug 14, 2026, 23:15Markus Müller: A New Base Editing Approach Targeting PCSK9 to Lower Cholesterol Levels
-
Aug 14, 2026, 23:14Chokri Ben Lamine: Avatrombopag in Hematology – Dosing and Monitoring